International Journal of Organ Transplantation Medicine最新文献_第2页

Anesthesia Aspects of Multivisceral Transplantation: A Case Series Study. 多脏器移植的麻醉方面:一个案例系列研究。

IF 0.7

International Journal of Organ Transplantation Medicine Pub Date : 2022-01-01

M B Khosravi, V Naderi-Boldaji, F Khalili, M A Sahmeddini, M H Eghbal, P Vatankhah, H Nikoupour, A Shamsaeefar, S Ghazanfar Tehran

{"title":"Anesthesia Aspects of Multivisceral Transplantation: A Case Series Study.","authors":"M B Khosravi, V Naderi-Boldaji, F Khalili, M A Sahmeddini, M H Eghbal, P Vatankhah, H Nikoupour, A Shamsaeefar, S Ghazanfar Tehran","doi":"","DOIUrl":"","url":null,"abstract":"Background: Multi-visceral transplantation (MvTx) usually refers to the transplantation of more than three intra-abdominal organs. A successful MvTx requires strong multidisciplinary teamwork of transplant surgeons, anesthesiologists, and intensivists.Case presentation: We present five cases of MvTx with a history of short bowel syndrome admitted to the Abu-Ali Sina Hospital, Shiraz, Iran from May 2019 to January 2020 and describe anesthetic considerations in MvTx. Subjects were identified (4F/1M) with a mean age of 43 years old (range 35-51). The most frequent cause of intestinal failure was portal vein thrombosis, followed by bowel gangrene and short bowel syndrome. The mean ±SD duration of the operation was 360±60 min. The bleeding volume was approximately 2600±1474 cc, and 4±1 bags of packed red blood cells were transfused. Sepsis was the main cause of death in our series.Conclusion: Careful preoperative planning, vigilant intraoperative anesthetic management, and prevention of postoperative infection are imperative to achieve the best outcomes.","PeriodicalId":14242,"journal":{"name":"International Journal of Organ Transplantation Medicine","volume":"13 2","pages":"71-77"},"PeriodicalIF":0.7,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10460526/pdf/ijotm-13-71.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10114192","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Current Situation and Prognostic Evolution of Combined Heart-lung Transplantation in a European Union Country. 欧盟国家联合心肺移植的现状及预后演变。

IF 0.7

International Journal of Organ Transplantation Medicine Pub Date : 2022-01-01

R Lopez-Vilella, M Gomez Bueno, F Gonzalez Vflchez, A Sole Jover, R Laporta Hernandez, R Vicente Guillen, A I Gonzalez Roman, I Sanchez-Lazaro, F Hernandez Perez, G Sales Badfa, M D M Cordoba Pelaez, S Torregrosa Puerta, A Forteza Gil, L Martinez Dolz, J Segovia Cubero, L Almenar Bonet

{"title":"Current Situation and Prognostic Evolution of Combined Heart-lung Transplantation in a European Union Country.","authors":"R Lopez-Vilella, M Gomez Bueno, F Gonzalez Vflchez, A Sole Jover, R Laporta Hernandez, R Vicente Guillen, A I Gonzalez Roman, I Sanchez-Lazaro, F Hernandez Perez, G Sales Badfa, M D M Cordoba Pelaez, S Torregrosa Puerta, A Forteza Gil, L Martinez Dolz, J Segovia Cubero, L Almenar Bonet","doi":"","DOIUrl":"","url":null,"abstract":"Background: This study aims to evaluate the entire experience in heart-lung transplantation (HLTx) in a country of the European Union with 47 million inhabitants according to the etiologies that motivated the procedure.Methods: A retrospective study on 1,751 consecutive transplants (HLTx: 78) was performed from 1990 to 2020 in two centers. Overall survival, adjusted for clinical profile and etiological subgroups, was compared. 7 subgroups were considered: 1) Cardiomyopathy with pulmonary hypertension (CM + PH). 2) Eisenmenger syndrome. 3) Congenital heart disease (CHD). 4) Idiopathic pulmonary arterial hypertension (IPAH). 5) Cystic fibrosis. 6) Chronic obstructive pulmonary disease (COPD)/Emphysema. 7) Diffuse interstitial lung disease (ILD).Results: Early mortality was 44% and that of the rest of the follow-up was 31%. There were differences between HTLx and HTx in survival, also comparing groups with a similar clinical profile with propensity score (p= 0.04). Median survival was low in CM + PH (18 days), ILD (29 days) and CHD (114 days), intermediate in Eisenmenger syndrome (600 days), and longer in IPAH, COPD/Emphysema and cystic fibrosis.Conclusion: HLTx has a high mortality. The etiological analysis is of the utmost interest to make the most of the organs and improve survival.","PeriodicalId":14242,"journal":{"name":"International Journal of Organ Transplantation Medicine","volume":"13 2","pages":"51-62"},"PeriodicalIF":0.7,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10460527/pdf/ijotm-13-51.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10114193","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

The lowest uric acid in kidney transplant and review of literature. 肾移植中最低尿酸及文献回顾。

IF 0.7

International Journal of Organ Transplantation Medicine Pub Date : 2022-01-01

J Roozbeh, A Dehghani, A Haghpanah, L Malekmakan

引用次数: 0

Reversible Calcineurin Inhibitor-associated Sensorimotor Polyneuropathy in a Lung Transplant Recipient: A Case Report. 可逆钙调磷酸酶抑制剂相关的感觉运动多发性神经病在肺移植受体:一个病例报告。

IF 0.7

International Journal of Organ Transplantation Medicine Pub Date : 2021-01-01

T Antychin, J A Zarowski, V Verplancke, J M H Hendriks, S K Yogeswaran, P Lauwers, K Lamote, J M Kwakkel-van Erp

引用次数: 0

Virtual Crossmatching in Kidney Transplantation, Shiraz Experience in Development of a Web-Based Program. 肾移植中的虚拟交叉匹配，设拉子基于web程序开发的经验。

IF 0.7

International Journal of Organ Transplantation Medicine Pub Date : 2021-01-01

N Jamshidian Tehrani, B Geramizadeh, S A Malekhosseini, S Nikeghbalian, A Bahador, S Gholami, G A Raees Jalali, J Roozbeh, M H Anbardar, N Soleimani, N Rasaei, S Mohammadzadeh

{"title":"Virtual Crossmatching in Kidney Transplantation, Shiraz Experience in Development of a Web-Based Program.","authors":"N Jamshidian Tehrani, B Geramizadeh, S A Malekhosseini, S Nikeghbalian, A Bahador, S Gholami, G A Raees Jalali, J Roozbeh, M H Anbardar, N Soleimani, N Rasaei, S Mohammadzadeh","doi":"","DOIUrl":"","url":null,"abstract":"Background: Kidney transplantation can increase survival and quality of life in patients with end-stage renal disease. In any allocation system, the crossmatch test plays an essential role in donor-recipient compatibility.Objective: In this study, we aim to test the benefits of a web-based program that captures HLA antibody analyses and provides a report to allow fast and accurate virtual crossmatches.Methods: One hundred potential recipients in the waiting list of renal transplants were selected. The included patients all had a complete HLA antibody profile. Also, 10 potential donors from previous kidney transplants (2020), with available HLA typing results for A, B, and DR locus, were also selected. A comparison was made between 100 recipients against ten potential donors, and virtual crossmatching (VXM) was performed by the web-based program and manually by an experienced immunologist.Results: The average time for a manual VXM was 30 minutes per patient, while the virtual cross web-based program took 5 minutes per patient. In 12% of the manual VXM cases, a secondary review of data improved final results. In two manual virtual crossmatches, the VXM results had errors in matching recipient antibodies with the donor HLA typing that could affect the final decision for transplantation.Conclusion: In conclusion, a web-based VXM program that assesses HLA data can accurately perform a VXM with fewer human errors. It is especially true for highly sensitized candidates.","PeriodicalId":14242,"journal":{"name":"International Journal of Organ Transplantation Medicine","volume":"12 2","pages":"20-25"},"PeriodicalIF":0.7,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8717962/pdf/ijotm-12-20.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39788019","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Case of Renal Aspergillosis after Heart Transplant: Diagnosis and Treatment. 心脏移植后肾曲霉病1例:诊断与治疗。

IF 0.7

International Journal of Organ Transplantation Medicine Pub Date : 2021-01-01

M Mahdavi, G Mortaz-Hejri, H Shahzadi, H R Pouraliakbar, A Amin, M Hesami, B Naghavi

引用次数: 0

COVID-19 in Kidney Transplantation. COVID-19在肾移植中的应用

IF 0.7

International Journal of Organ Transplantation Medicine Pub Date : 2021-01-01

P K Garcia-Padilla, G Elías, P Paola, O Viviana

引用次数: 0

Impact of G-CSF Therapy on Leukopenia and Acute Rejection Following Kidney Transplantation. G-CSF治疗对肾移植后白细胞减少和急性排斥反应的影响。

IF 0.7

International Journal of Organ Transplantation Medicine Pub Date : 2021-01-01

J Schneider, M Henningsen, P Pisarski, G Walz, B Jänigen

{"title":"Impact of G-CSF Therapy on Leukopenia and Acute Rejection Following Kidney Transplantation.","authors":"J Schneider, M Henningsen, P Pisarski, G Walz, B Jänigen","doi":"","DOIUrl":"","url":null,"abstract":"Background: Leukopenia is a common problem after kidney transplantation. The therapeutic approach typically includes a reduction of the immunosuppressive therapy, which is associated with an increased risk of rejection and allograft loss. Granulocyte colony-stimulating factor (G-CSF) is used as a therapeutic option to raise the leukocyte blood count; however, the effect on acute rejections is controversial.Objective: The goal of this study is to examine the incidence of acute rejections following G-CSF therapy.Methods: We retrospectively evaluated patients with leukopenia following kidney transplantation and GCSF therapy between January 2007 and December 2017 at our center compared to controls with matched minimal leucocyte blood count in a matched pair analysis.Results: We identified 12 patients, who received G-CSF therapy with a cumulative dose of 10.74 µg/kg body weight over a time frame of 4.3 days. G-CSF therapy resulted in a significantly shorter time period with leucocytes <3,000/µL (9.5 vs. 16.6 days), but also trended towards an increased risk of rejection within the next 30 days with three patients in the G-CSF group and no patient in the control group (p=0.06) developing an acute biopsy-proven rejection. Infection and mortality rate in the subsequent year were not different between groups.Conclusion: G-CSF therapy decreases the duration of leukopenia post-kidney transplantation, but may also increase the risk of an acute rejection.","PeriodicalId":14242,"journal":{"name":"International Journal of Organ Transplantation Medicine","volume":"12 2","pages":"1-8"},"PeriodicalIF":0.7,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8717965/pdf/ijotm-12-1.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39788017","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Importance of miR-UL-148D Expression Pattern in Cytomegalovirus Infected Transplant Patients. 巨细胞病毒感染移植患者体内 miR-UL-148D 表达模式的重要性

IF 0.3

International Journal of Organ Transplantation Medicine Pub Date : 2021-01-01

M Golshan, R Yaghobi, B Geramizadeh, A Afshari, J Roozbeh, S A Malek-Hosseini

{"title":"Importance of miR-UL-148D Expression Pattern in Cytomegalovirus Infected Transplant Patients.","authors":"M Golshan, R Yaghobi, B Geramizadeh, A Afshari, J Roozbeh, S A Malek-Hosseini","doi":"","DOIUrl":"","url":null,"abstract":"Background: MicroRNAs (miRNAs) are endogenous, 18-22 nucleotide non-coding RNA molecules. Human cytomegalovirus (HCMV) is a ubiquitous and particular herpes virus that encodes miRNAs, which increases gradually in the presence of infection. One of the important viral miRNAs is HCMV-miRUL-148D, which plays a role in establishing and maintaining viral latency.Objective: The current study aimed to evaluate the expression levels of HCMV-miRUL-148D in active and inactive HCMV infected transplant patient groups compared to healthy individuals.Methods: Total RNA was extracted from blood samples of 60 solid organ transplant patients and 30healthy controls. In-house SYBR Green Real-Time PCR evaluated the expression levels of studied miRNAand gene.Results: The expression level of the UL-148D gene was significantly higher in the active HCMV infectedpatients (p=0.001) compared to other groups. While the miRUL-148D expression level significantly increased in the inactive HCMV-infected patients (p<0.001) compared to other groups.Conclusion: Increased miRUL-148D expression level in the inactive HCMV-infected transplant patients indicates the potential role of this miRUL-148D as a biomarker of the HCMV latent stage.","PeriodicalId":14242,"journal":{"name":"International Journal of Organ Transplantation Medicine","volume":"12 4","pages":"46-54"},"PeriodicalIF":0.3,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9758995/pdf/ijotm-12-46.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10497125","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

CNS Post-Transplant Lymphoproliferative Disorder in a Heart Recipient: A Case Report. 心脏受者中枢神经系统移植后淋巴细胞增生性疾病1例报告。

IF 0.7

International Journal of Organ Transplantation Medicine Pub Date : 2021-01-01

A Amin, M Chenaghlou, E Zare, N Naderi, S Taghavi

引用次数: 0